![Junichi Kawagoe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Junichi Kawagoe
Direktor/Vorstandsmitglied bei Kowa Pharmaceutical Europe Co. Ltd.
Profil
Junichi Kawagoe is currently a Director at Kowa Pharmaceutical Europe Co. Ltd., a Director at Kowa Research Europe Ltd., a Member-Supervisory Board at Kowa Holdings Europe AG, and a Member-Supervisory Board at Kowa Pharmaceutical Europe AG.
Previously, he was a Director-Licensing Department at Kowa Co., Ltd.
and a Director at Kowa Pharmaceuticals America, Inc.
Aktive Positionen von Junichi Kawagoe
Unternehmen | Position | Beginn |
---|---|---|
Kowa Pharmaceutical Europe Co. Ltd.
![]() Kowa Pharmaceutical Europe Co. Ltd. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceutical Europe Co. Ltd. engages in the manufacture of pharmaceutical products. The company was founded in 1947 and is headquartered in Wokingham, the United Kingdom. | Direktor/Vorstandsmitglied | 16.08.2006 |
Kowa Research Europe Ltd.
![]() Kowa Research Europe Ltd. Investment Trusts/Mutual FundsMiscellaneous Kowa Research Europe Ltd. engages in research and experimental development on social sciences and humanities. The firm develops NK-104, Pitavastatin; K-877, Pemafibrate; K-333, Peretinoin; and K-115, Ripasudil compounds. The company was founded on January 12, 1999 and is headquartered in Wokingham, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Kowa Holdings Europe AG
![]() Kowa Holdings Europe AG BiotechnologyHealth Technology Kowa Holdings Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies. It focuses on firms that specialize in research, development, production, trade, as well as sale and wholesale of pharmaceutical and chemical products, fashion, interior design, medical products, and lenses. The company was founded on February 8, 2016 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - |
Kowa Pharmaceutical Europe AG
![]() Kowa Pharmaceutical Europe AG Financial ConglomeratesFinance Kowa Pharmaceutical Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies that specialize in research, development, production, trade, distribution, as well as wholesale of pharmaceutical, medical, health, and chemical products. The company was founded on December 6, 2016 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Junichi Kawagoe
Unternehmen | Position | Ende |
---|---|---|
Kowa Co., Ltd.
![]() Kowa Co., Ltd. Wholesale DistributorsDistribution Services Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan. | Corporate Officer/Principal | - |
Kowa Pharmaceuticals America, Inc.
![]() Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Kowa Co., Ltd.
![]() Kowa Co., Ltd. Wholesale DistributorsDistribution Services Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan. | Distribution Services |
Kowa Pharmaceuticals America, Inc.
![]() Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Health Technology |
Kowa Pharmaceutical Europe Co. Ltd.
![]() Kowa Pharmaceutical Europe Co. Ltd. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceutical Europe Co. Ltd. engages in the manufacture of pharmaceutical products. The company was founded in 1947 and is headquartered in Wokingham, the United Kingdom. | Health Technology |
Kowa Holdings Europe AG
![]() Kowa Holdings Europe AG BiotechnologyHealth Technology Kowa Holdings Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies. It focuses on firms that specialize in research, development, production, trade, as well as sale and wholesale of pharmaceutical and chemical products, fashion, interior design, medical products, and lenses. The company was founded on February 8, 2016 and is headquartered in Zurich, Switzerland. | Health Technology |
Kowa Pharmaceutical Europe AG
![]() Kowa Pharmaceutical Europe AG Financial ConglomeratesFinance Kowa Pharmaceutical Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies that specialize in research, development, production, trade, distribution, as well as wholesale of pharmaceutical, medical, health, and chemical products. The company was founded on December 6, 2016 and is headquartered in Zurich, Switzerland. | Finance |
Kowa Research Europe Ltd.
![]() Kowa Research Europe Ltd. Investment Trusts/Mutual FundsMiscellaneous Kowa Research Europe Ltd. engages in research and experimental development on social sciences and humanities. The firm develops NK-104, Pitavastatin; K-877, Pemafibrate; K-333, Peretinoin; and K-115, Ripasudil compounds. The company was founded on January 12, 1999 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous |